BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 34533582)

  • 21. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
    Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
    Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension in an experimental model of systemic lupus erythematosus occurs independently of the renal nerves.
    Mathis KW; Venegas-Pont M; Flynn ER; Williams JM; Maric-Bilkan C; Dwyer TM; Ryan MJ
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R711-9. PubMed ID: 23926131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease recurrence in paediatric renal transplantation.
    Cochat P; Fargue S; Mestrallet G; Jungraithmayr T; Koch-Nogueira P; Ranchin B; Zimmerhackl LB
    Pediatr Nephrol; 2009 Nov; 24(11):2097-108. PubMed ID: 19247694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-mediated complications during interferon therapy in hematological patients.
    Raanani P; Ben-Bassat I
    Acta Haematol; 2002; 107(3):133-44. PubMed ID: 11978934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What is the role of autoimmune processes in nephropathies?].
    Ehrich JH; Oemar BS; Bruijn JA
    Monatsschr Kinderheilkd; 1990 Nov; 138(11):724-9. PubMed ID: 2290431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic unilateral cervical vagotomy reduces renal inflammation, blood pressure, and renal injury in a mouse model of lupus.
    Pham GS; Shimoura CG; Chaudhari S; Kulp DV; Mathis KW
    Am J Physiol Renal Physiol; 2020 Aug; 319(2):F155-F161. PubMed ID: 32538149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging immunotherapies for autoimmune kidney disease.
    Foster MH; Ord JR
    Hum Vaccin Immunother; 2019; 15(4):876-890. PubMed ID: 30550361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA and kidney disease: from associations to mechanisms.
    Robson KJ; Ooi JD; Holdsworth SR; Rossjohn J; Kitching AR
    Nat Rev Nephrol; 2018 Oct; 14(10):636-655. PubMed ID: 30206339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of complement in autoimmune renal disease.
    Seelen MA; Daha MR
    Autoimmunity; 2006 Aug; 39(5):411-5. PubMed ID: 16923541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG4-related kidney disease--A review.
    Pradhan D; Pattnaik N; Silowash R; Mohanty SK
    Pathol Res Pract; 2015 Oct; 211(10):707-11. PubMed ID: 26341570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease.
    Taylor EB; Ryan MJ
    J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiphospholipid antibodies and renal involvement.
    Gigante A; Gasperini ML; Cianci R; Barbano B; Giannakakis K; Di Donato D; Fuiano G; Amoroso A
    Am J Nephrol; 2009; 30(5):405-12. PubMed ID: 19713697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The NLRP3 inflammasome in kidney disease and autoimmunity.
    Hutton HL; Ooi JD; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2016 Sep; 21(9):736-44. PubMed ID: 27011059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathophysiology of hypertension in systemic lupus erythematosus.
    Ryan MJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R1258-67. PubMed ID: 19158408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal vascular complications of systemic lupus erythematosus.
    Appel GB; Pirani CL; D'Agati V
    J Am Soc Nephrol; 1994 Feb; 4(8):1499-515. PubMed ID: 8025223
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
    Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
    Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmunity: an underlying factor in the pathogenesis of hypertension.
    Mathis KW; Broome HJ; Ryan MJ
    Curr Hypertens Rep; 2014 Apr; 16(4):424. PubMed ID: 24535221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological spectrum of glomerular disease in patients with renal insufficiency: a single-center study in Northeastern China.
    Chen L; Luodelete M; Dong C; Li B; Zhang W; Nie P; Liu J; Chen X; Luo P
    Ren Fail; 2019 Nov; 41(1):473-480. PubMed ID: 31198075
    [No Abstract]   [Full Text] [Related]  

  • 39. Rag1-null Dahl SS rats reveal that adaptive immune mechanisms exacerbate high protein-induced hypertension and renal injury.
    Abais-Battad JM; Lund H; Fehrenbach DJ; Dasinger JH; Mattson DL
    Am J Physiol Regul Integr Comp Physiol; 2018 Jul; 315(1):R28-R35. PubMed ID: 29537860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasticity and heterogeneity of Th17 in immune-mediated kidney diseases.
    Krebs CF; Panzer U
    J Autoimmun; 2018 Feb; 87():61-68. PubMed ID: 29275837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.